The study, conducted in 2022, highlights significant variations in glaucoma prevalence across different demographic groups, ...

According to OKYO Pharma, OK-101 is the first drug candidate to enroll patients specifically diagnosed with neuropathic ...

The company will seek a strategic partner to continue development of APX3330, an oral small-molecule inhibitor of Ref-1 for ...

In a paper presented at the American Academy of Ophthalmology annual meeting in Chicago, Jonathan Tan, a third year medical student at the Icahn School of Medicine at Mount Sinai detailed the study on ...

This year’s conference, in Chicago, showcased a diverse array of practice-changing data across multiple ophthalmic specialties, including advances in cataract surgery, glaucoma management, and retinal ...

Steven Dell, MD, shares insights from his first SMILE procedure case, detailing key surgical steps and the patient's postoperative experience.